XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 106 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,817,179 | +1.9% | 1,696,524 | +0.0% | 0.00% | 0.0% |
| Q1 2024 | $3,747,614 | +3.0% | 1,695,753 | +9.5% | 0.00% | 0.0% |
| Q4 2023 | $3,637,694 | -14.0% | 1,547,955 | -31.9% | 0.00% | 0.0% |
| Q3 2023 | $4,229,908 | -10.8% | 2,274,144 | +25.6% | 0.00% | 0.0% |
| Q2 2023 | $4,743,109 | +513779.6% | 1,810,347 | +160.8% | 0.00% | +100.0% |
| Q4 2022 | $923 | -99.9% | 694,043 | +25.6% | 0.00% | 0.0% |
| Q2 2022 | $851,000 | -76.8% | 552,549 | -61.5% | 0.00% | -50.0% |
| Q1 2022 | $3,675,000 | +466.3% | 1,435,622 | +547.9% | 0.00% | – |
| Q4 2021 | $649,000 | – | 221,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $9,300,000 | 12.49% |
| Stonepine Capital Management, LLC | 11,647,417 | $17,937,000 | 8.34% |
| SINECERA CAPITAL, LLC | 253,101 | $390,000 | 0.44% |
| NEA Management Company, LLC | 3,246,785 | $5,000,000 | 0.26% |
| ARMISTICE CAPITAL, LLC | 5,824,000 | $8,969,000 | 0.16% |
| DELTEC ASSET MANAGEMENT LLC | 406,000 | $625,000 | 0.15% |
| Alpine Global Management, LLC | 350,000 | $539,000 | 0.14% |
| Redmile Group, LLC | 1,046,587 | $1,612,000 | 0.06% |
| IHT Wealth Management, LLC | 337,387 | $520,000 | 0.05% |
| TUDOR INVESTMENT CORP ET AL | 960,111 | $1,479,000 | 0.04% |